Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error...

Area of Science:

• Health Sciences
• Patient Safety
• Clinical Research Methodology

Background:

• Classifying patient harm from medication errors is complex and lacks standardization.
• Existing harm assessment tools vary widely and often lack reliability and validity data.
• Previous studies often fail to specify if actual or potential harm was assessed, hindering comparability.

Purpose of the Study:

• To systematically synthesize existing harm classification tools for medication errors.
• To develop a novel, standardized tool, the Harm Associated with Medication Error Classification (HAMEC), for consistent harm assessment.
• To provide a reproducible methodology for classifying medication-related patient harm in clinical and research settings.

Main Methods:

• A systematic review and synthesis of existing medication error harm classification tools.
• Development of the Harm Associated with Medication Error Classification (HAMEC) tool.
• Inclusion of explicit application processes and guiding descriptors to enhance usability and reduce misclassification.

Main Results:

• The Harm Associated with Medication Error Classification (HAMEC) tool was derived through a systematic synthesis of existing methods.
• HAMEC offers a standardized approach to classifying patient harm from medication errors.
• The tool includes clear descriptors and an explicit application process to ensure consistency and comparability across studies.

Conclusions:

• The Harm Associated with Medication Error Classification (HAMEC) tool addresses the need for standardized, reproducible harm assessment in medication safety.
• HAMEC is designed for use in both clinical practice and research, supporting efforts to measure and reduce medication-related harm.
• This standardized tool is crucial for advancing the World Health Organization's goal of reducing global medication-related harm.